Lexicon Pharmaceuticals (LXRX) News Today $0.95 +0.12 (+15.20%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LXRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period While institutions own 28% of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), private equity firms are its largest shareholders with 48% ownershipJune 30 at 8:33 PM | finance.yahoo.comLXRX - Lexicon Pharmaceuticals Inc Price vs Fair Value - MorningstarJune 26, 2025 | morningstar.comMLexicon Pharmaceuticals (NASDAQ:LXRX) Earns Buy Rating from HC WainwrightJune 26, 2025 | americanbankingnews.comLexicon Pharmaceuticals' (LXRX) Buy Rating Reiterated at HC WainwrightJune 24, 2025 | marketbeat.comH.C. Wainwright reiterates buy rating on Lexicon Pharmaceuticals stockJune 24, 2025 | investing.comLexicon Pharmaceuticals (NASDAQ:LXRX) Stock Crosses Above 200 Day Moving Average - Here's What HappenedJune 24, 2025 | marketbeat.comData Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA)June 23, 2025 | globenewswire.comLexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)June 18, 2025 | globenewswire.comLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Given Consensus Recommendation of "Hold" by AnalystsJune 15, 2025 | marketbeat.comLexicon Pharmaceuticals surges 67% following InvestingPro's Fair Value signalJune 8, 2025 | investing.comLexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comWoodline Partners LP Lowers Stock Holdings in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)May 29, 2025 | marketbeat.comLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Average Rating of "Hold" from AnalystsMay 23, 2025 | marketbeat.comPoint72 Asset Management L.P. Acquires 7,758,371 Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)May 22, 2025 | marketbeat.comLexicon Pharmaceuticals, Inc. (LXRX): Analysts See 285% Upside PotentialMay 21, 2025 | insidermonkey.comLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Stock Holdings Lifted by Tang Capital Management LLCMay 21, 2025 | marketbeat.comLexicon Pharmaceuticals’ Sotagliflozin: Promising Phase 3 Developments Justify Buy RatingMay 20, 2025 | tipranks.comSONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of CardiologyMay 19, 2025 | globenewswire.comLexicon Pharmaceuticals, Inc.: Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 19, 2025 | finanznachrichten.deLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesMay 17, 2025 | finance.yahoo.comLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2025 Earnings Call TranscriptMay 15, 2025 | msn.comLexicon targets late 2025 Phase 3 start for pilavapadin and expands LX9851 partnership with Novo NordiskMay 14, 2025 | msn.comLexicon Pharmaceuticals Inc (LXRX) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ...May 14, 2025 | gurufocus.comQ1 2025 Lexicon Pharmaceuticals Inc Earnings Call TranscriptMay 13, 2025 | gurufocus.comLexicon Pharmaceuticals (LXRX) Secures Major Licensing Deal with Novo NordiskMay 13, 2025 | gurufocus.comLexicon Pharmaceuticals, Inc. (LXRX) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comLexicon Pharmaceuticals Inc (LXRX) Q1 2025 Earnings: EPS Beats Estimates at -$0. ...May 13, 2025 | gurufocus.comLexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 13, 2025 | globenewswire.comLexicon Pharmaceuticals Q1 2025 Earnings PreviewMay 12, 2025 | msn.comLexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor ConferenceMay 6, 2025 | gurufocus.comLexicon Pharmaceuticals to Present at the 3rd Annual H.C. ...May 6, 2025 | gurufocus.comLexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor ConferenceMay 6, 2025 | globenewswire.comLexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025May 6, 2025 | gurufocus.comLexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025May 6, 2025 | globenewswire.comSchonfeld Strategic Advisors LLC Has $5.58 Million Position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)May 5, 2025 | marketbeat.comBoothbay Fund Management LLC Purchases Shares of 480,822 Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)May 4, 2025 | marketbeat.comNantahala Capital Management LLC Acquires 4,300,000 Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)April 30, 2025 | marketbeat.comLexicon Pharmaceuticals (LXRX) to Post Quarterly Earnings on ThursdayApril 26, 2025 | marketbeat.comLexicon Pharmaceuticals (NASDAQ:LXRX) Now Covered by Analysts at StockNews.comApril 22, 2025 | marketbeat.comLexicon Pharmaceuticals (NASDAQ:LXRX) Coverage Initiated at StockNews.comApril 14, 2025 | marketbeat.comStockNews.com Begins Coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX)April 6, 2025 | marketbeat.comLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Short Interest UpdateApril 3, 2025 | marketbeat.comLexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare ConferenceApril 2, 2025 | globenewswire.comLexicon Pharmaceuticals' (LXRX) Buy Rating Reaffirmed at HC WainwrightMarch 29, 2025 | marketbeat.comLexicon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:LXRX)March 29, 2025 | marketbeat.comStock Traders Purchase Large Volume of Lexicon Pharmaceuticals Call Options (NASDAQ:LXRX)March 29, 2025 | marketbeat.comLexicon stock soars on Novo Nordisk licensing dealMarch 29, 2025 | za.investing.comLexicon announces exclusive license agreement with Novo Nordisk for LX9851March 29, 2025 | markets.businessinsider.comLexicon announces exclusive license agreement with Novo Nordisk for LX9851March 29, 2025 | markets.businessinsider.comWhat 6 Analyst Ratings Have To Say About Lexicon PharmaceuticalsMarch 29, 2025 | benzinga.com Get Lexicon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address LXRX Media Mentions By Week LXRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LXRX News Sentiment▼0.520.90▲Average Medical News Sentiment LXRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LXRX Articles This Week▼84▲LXRX Articles Average Week Get Lexicon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVAX News OPK News GERN News RGLS News MYGN News ZBIO News EBS News RIGL News XOMA News VNDA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LXRX) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexicon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexicon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
